EUVIMEDEUVIMED entdecken
Crossref

In Silico Comparison of AI-Generated Pharmacophore Analogs Against Mycobacterium tuberculosis Target Proteins with Traditional Finding of Analogs for Molecular Docking Approaches

Shweta Kesrwani, Garima Awasthi, Ankur Mohan

International Journal of Innovative Science and Research Technology · 16.06.2026 · 306

DOI: 10.38124/ijisrt/26jun067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 16.06.2026. Verfasst von Shweta Kesrwani und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis caused by Mycobacterium tuberculosis is one of the main factors responsible for fatal lung diseases and affects the developing countries more because these regions suffer from tuberculosis infections owing to their cold climate conditions. The rise in number of cases related to MDR-TB and XDR-TB has made it very important that new chemical templates be created for inhibiting these enzymes produced by mycobacteria. The present study aims at determining whether there is any ability of these inhibitors to prevent the three important enzymes of MTB, which include DprE1 hexagonal crystal structure (PDB ID: 4FEH), InhA enoyl acyl carrier protein reductase (PDB ID: 5W07) and C171Q KasA beta ketoacyl synthase (PDB ID: 4C6X). Overall, 61 ligands obtained from the PubChem database underwent screening via Lipinski's Rule of Five, transformation via Open Babel 3.1.1, optimization by using torsional calculations, and conversion to the PDBQT file format. For characterizing the active sites, DogSiteScorer was used, which is part of ProteinsPlus, and then docking through PyRx 0.8 with the use of AutoDock Vina as a docking algorithm. Delamanid (CID: 6480466) demonstrated stronger binding to DprE1 (-12.9 kcal/mol), InhA (-12.3 kcal/mol), and KasA (-12.1 kcal/mol). The structure of the compound was analyzed by considering its interactions with the proteins using BIOVIA Discovery Studio. The coordinates of the pharmacophores from the Delamanid molecules were used for the virtual screening of ZINCPharmer and fragment generation via DeepFrag. AI-based pharmacophore optimization is one of the promising approaches in designing new anti-tuberculosis medications.

Zitieren

APA

Kesrwani, S., Awasthi, G., & Mohan, A. (2026). In Silico Comparison of AI-Generated Pharmacophore Analogs Against Mycobacterium tuberculosis Target Proteins with Traditional Finding of Analogs for Molecular Docking Approaches. International Journal of Innovative Science and Research Technology, 306. https://doi.org/10.38124/ijisrt/26jun067

Vancouver

Kesrwani S, Awasthi G, Mohan A. In Silico Comparison of AI-Generated Pharmacophore Analogs Against Mycobacterium tuberculosis Target Proteins with Traditional Finding of Analogs for Molecular Docking Approaches. International Journal of Innovative Science and Research Technology. 2026:306. doi:10.38124/ijisrt/26jun067

BibTeX
@article{Kesrwani2026,
  author = {Kesrwani, Shweta and Awasthi, Garima and Mohan, Ankur},
  title = {In Silico Comparison of AI-Generated Pharmacophore Analogs Against Mycobacterium tuberculosis Target Proteins with Traditional Finding of Analogs for Molecular Docking Approaches},
  journal = {International Journal of Innovative Science and Research Technology},
  year = {2026},
  pages = {306},
  doi = {10.38124/ijisrt/26jun067}
}
Kostenlos starten →